The Journal of Urology
Volume 157, Issue 4 , Pages 1208-1212 , April 1997

Pheochromocytoma: Study of 50 Cases

,Accepted 16 August 1996.

REFERENCES 

  1. Goldifien A . Phaechromocytoma . Clin. Endocr. Metab. . 1991;10:606
  2. Manger WM , Gifford RW . Phaechromocytoma-diagnosis and management . N. Y. State J. Med. . 1980;80:216
  3. Sutton MG , Sheps SG , Lie JT . Prevalence of clinically unsuspected phaeochromocytoma. Review of a 50-year autopsy series . Mayo Clin. Proc. . 1981;56:354
  4. Juan D . Pharmacologic agents in the management of pheochromocytoma . South. Med. J. . 1982;75:211
  5. Bayes T . An essay towards solving a problem in the doctrine of chances . MD Computing . 1991;8:157
  6. Stenstrom G , Svardsudd K . Pheochromocytoma in Sweden, 1958-1981: an analysis of the National Cancer Registry Data . Acta Med. Scand. . 1986;220:225
  7. Bravo EL , Tarazi RC , Gifford RW , Stewart BH . Circulating and urinary catecholamines in pheochromocytoma. Diagnostic and pathophysiologic implications . New Engl. J. Med. . 1979;301:682
  8. Riccardi VM . Von Recklinghausen neurofibromatosis . New Engl. J. Med. . 1981;305:1617
  9. Sipple JH . The association of pheochromocytoma with carcinoma of the thyroid gland . Amer. J. Med. . 1961;31:163
  10. Schimke RN . Multiple endocrine neoplasia-how many syndromes? Amer . J. Med. Genet. . 1990;37:375
  11. Maher ER, Yates JR, Harries R, Benjamin C, Harris R, Moore AT, et al. Clinical features and natural history of von Hippel Lindau disease . Quart. J. Med. . 1990;77:1151
  12. Mulligan LM, Kwok JB, Healey CS, Elsdon MJ, Eng C, Gardner E, et al. Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A . Nature . 1993;363:458
  13. Latif F, Tory K, Gnarra J, Yao M, Duh FM, Orcutt MJ, et al. Identification of the von Hippel-Lindau disease tumor supressor gene . Science . 1993;260:1317
  14. Bravo EL . Evolving concepts in the pathophysiology, diagnosis and treatment of pheochromocytoma . Endocr. Rev. . 1994;15:356
  15. Graham PE , Smythe GA , Edwards GA , Lazarus L . Laboratory diagnosis of phaeochromocytoma: which analytes should we measure? Ann . Clin. Biochem. . 1993;30:129
  16. Bravo, E. L. and Sahag, G. O. R.: Preoperative localization of pheochromocytoma: a prospective comparison of Iodo 131 metaiodobenzylquanidine and abdominal computed tomography. Read at European meeting on hypertension, Milan, Italy, abstract 122, June 1989.
  17. Halpern A, Marcus WEF, Martins R, Pereira MAA, Nussenzveig DR, Lucon AM, et al. Feocromocitoma-apresenta de quatro casos preparados para a cirurgia com prazosin e revisao da literatura . Ang. Brasil. Endocrin. Metabol. . 1985;29:94
  18. Concepcion RS , Koch MO , MacDougal WS , Stewart JR , Merril WH . Management of primary nonrenal parenchymal malignancies with vena caval thrombus . J. Urol. . 1991;145:243
  19. Harper MA , Murnaghan GA , Kennedy L , Hadden DR , Atkinson AB . Phaeochromocytoma in pregnancy: five cases and a review of the literature . Brit. J. Obst. Gynaec. . 1989;96:594
  20. Venuto R , Burstein P , Schneider R . Pheochromocytoma: antepartum diagnosis and management with tumor resection in the puerperium . Amer. J. Obst. Gynec. . 1984;15:431
  21. Schlumberger M, Gicquel C, Lumbroso J, Tenenbaum F, Comoy E, Bosq J, et al. Malignant pheochromocytoma: clinical, biological, histologic and therapeutic data in a series of 20 patients with distant metastases . J. Endocr. Invest. . 1992;15:631
  22. Mornex R , Badet C , Peyrin L . Malignant pheochromocytoma: a series of 14 cases observed between 1966 and 1990 . J. Endocr. Invest. . 1992;15:643
  23. Proye C , Vix M , Goropoulos A , Kerlo P , Lecomte-Houcke M . High incidence of malignant pheochromocytoma in a surgical unit: 26 cases out of 100 patients operated from 1971 to 1991 . J. Endocr. Invest. . 1992;15:651

PII: S0022-5347(01)64925-5

The Journal of Urology
Volume 157, Issue 4 , Pages 1208-1212 , April 1997